Matches in Wikidata for { <http://www.wikidata.org/entity/Q87561915> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- Q87561915 description "2014 թվականի օգոստոսի 12-ին հրատարակված գիտական հոդված" @default.
- Q87561915 description "article scientifique publié en 2014" @default.
- Q87561915 description "artículu científicu espublizáu n'agostu de 2014" @default.
- Q87561915 description "im August 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q87561915 description "scientific article published on 12 August 2014" @default.
- Q87561915 description "wetenschappelijk artikel" @default.
- Q87561915 description "наукова стаття, опублікована в серпні 2014" @default.
- Q87561915 name "Does tumoral (111)In-ibritumomab accumulation correlate with therapeutic effect and outcome in relapsed or refractory low-grade B-cell lymphoma patients undergoing (90)Y-ibritumomab radioimmunotherapy?" @default.
- Q87561915 name "Does tumoral (111)In-ibritumomab accumulation correlate with therapeutic effect and outcome in relapsed or refractory low-grade B-cell lymphoma patients undergoing (90)Y-ibritumomab radioimmunotherapy?" @default.
- Q87561915 type Item @default.
- Q87561915 label "Does tumoral (111)In-ibritumomab accumulation correlate with therapeutic effect and outcome in relapsed or refractory low-grade B-cell lymphoma patients undergoing (90)Y-ibritumomab radioimmunotherapy?" @default.
- Q87561915 label "Does tumoral (111)In-ibritumomab accumulation correlate with therapeutic effect and outcome in relapsed or refractory low-grade B-cell lymphoma patients undergoing (90)Y-ibritumomab radioimmunotherapy?" @default.
- Q87561915 prefLabel "Does tumoral (111)In-ibritumomab accumulation correlate with therapeutic effect and outcome in relapsed or refractory low-grade B-cell lymphoma patients undergoing (90)Y-ibritumomab radioimmunotherapy?" @default.
- Q87561915 prefLabel "Does tumoral (111)In-ibritumomab accumulation correlate with therapeutic effect and outcome in relapsed or refractory low-grade B-cell lymphoma patients undergoing (90)Y-ibritumomab radioimmunotherapy?" @default.
- Q87561915 P1433 Q87561915-57BFB22C-CCEF-4465-A4EE-D456720E6A4A @default.
- Q87561915 P1476 Q87561915-05C87D98-CD23-4FEB-909F-1DE3A874E5AB @default.
- Q87561915 P2093 Q87561915-528ABB79-2B8D-44A4-B51C-273A226A0DCF @default.
- Q87561915 P2093 Q87561915-64B60D72-D286-4381-B27D-E227BA8B66D0 @default.
- Q87561915 P2093 Q87561915-C5F8F626-B3BC-4B8A-935C-8992BBFA5C42 @default.
- Q87561915 P2093 Q87561915-E12CE627-DDA9-4E61-AE18-CDDDBFDF3A3A @default.
- Q87561915 P2093 Q87561915-E8E1E9E0-6745-4A86-9E0B-6E80BD8D7DCF @default.
- Q87561915 P2860 Q87561915-0885D4C4-5D6A-4637-873B-22D2636A105E @default.
- Q87561915 P2860 Q87561915-10E87448-54DE-4F2D-AFE1-566482036CD2 @default.
- Q87561915 P2860 Q87561915-1878106B-8EAA-421D-9F2C-9ECDF771C819 @default.
- Q87561915 P2860 Q87561915-1D274AB8-C686-4C57-9A6F-AD81F229B29C @default.
- Q87561915 P2860 Q87561915-1F68C3E1-1892-4492-919D-5FCFF82C350D @default.
- Q87561915 P2860 Q87561915-277E1BE0-48F7-4949-B002-011075DC7C0E @default.
- Q87561915 P2860 Q87561915-2A758AC8-EED7-4E12-8A5F-39565F4CB44C @default.
- Q87561915 P2860 Q87561915-2AE0D1D4-2295-4C6F-A079-D8399ABA0510 @default.
- Q87561915 P2860 Q87561915-4DD88E51-7088-4AA0-99D9-3260D0A9A792 @default.
- Q87561915 P2860 Q87561915-641147C6-CA68-49A1-9DA0-ACF3FA9F39B4 @default.
- Q87561915 P2860 Q87561915-8880395C-42AB-42CC-9674-350AF494041F @default.
- Q87561915 P2860 Q87561915-8A3E139E-A3AD-4115-8FA7-71A136D8C1DD @default.
- Q87561915 P2860 Q87561915-9ABE3B4C-E189-4B5F-A437-C0C312F7CCE0 @default.
- Q87561915 P2860 Q87561915-A893039E-E9D2-43C6-AA4F-48F24D7E2C3B @default.
- Q87561915 P2860 Q87561915-AD0C7002-9042-4359-838B-59A3F60BBE12 @default.
- Q87561915 P2860 Q87561915-D3834D8B-65D8-4B1F-BC63-7E2E4BD94057 @default.
- Q87561915 P2860 Q87561915-D72EB403-1EEE-4BB5-BAD5-9522AB269A20 @default.
- Q87561915 P2860 Q87561915-DC5333CC-056D-4A19-BB63-1149AE780B94 @default.
- Q87561915 P2860 Q87561915-F0DA512B-FF5A-4430-B5B3-0B82C0ED2075 @default.
- Q87561915 P2860 Q87561915-F4EACB4B-6F17-4E7C-B3E2-122D3D8FD2EB @default.
- Q87561915 P2860 Q87561915-FC7FC158-06CA-43F2-A6F2-AD8921E93452 @default.
- Q87561915 P304 Q87561915-78EB9055-70A8-453B-BE82-AB993183F9A3 @default.
- Q87561915 P31 Q87561915-23B53206-1158-455C-B821-646B986D3C07 @default.
- Q87561915 P356 Q87561915-DA24F065-85F5-4AD8-B0CF-07BC634983A7 @default.
- Q87561915 P433 Q87561915-AA1BB5B0-64C8-449E-99DE-4810B39625BB @default.
- Q87561915 P478 Q87561915-F550D144-1FCD-4A47-B459-26FE0B4EE884 @default.
- Q87561915 P577 Q87561915-EB381B31-802E-4F21-9C90-A8D165E70612 @default.
- Q87561915 P698 Q87561915-9572724B-CC51-4BC9-905E-F2C0041318EC @default.
- Q87561915 P921 Q87561915-0C505251-A520-44AD-9881-6C422663B206 @default.
- Q87561915 P356 S00330-014-3378-4 @default.
- Q87561915 P698 25117746 @default.
- Q87561915 P1433 Q5413071 @default.
- Q87561915 P1476 "Does tumoral (111)In-ibritumomab accumulation correlate with therapeutic effect and outcome in relapsed or refractory low-grade B-cell lymphoma patients undergoing (90)Y-ibritumomab radioimmunotherapy?" @default.
- Q87561915 P2093 "Ilseung Choi" @default.
- Q87561915 P2093 "Kenji Shinozaki" @default.
- Q87561915 P2093 "Koichiro Kaneko" @default.
- Q87561915 P2093 "Makoto Nakagawa" @default.
- Q87561915 P2093 "Naokuni Uike" @default.
- Q87561915 P2860 Q28250452 @default.
- Q87561915 P2860 Q33342594 @default.
- Q87561915 P2860 Q33343445 @default.
- Q87561915 P2860 Q33402171 @default.
- Q87561915 P2860 Q33837310 @default.
- Q87561915 P2860 Q35120243 @default.
- Q87561915 P2860 Q37129904 @default.
- Q87561915 P2860 Q39591787 @default.
- Q87561915 P2860 Q41982455 @default.
- Q87561915 P2860 Q43165951 @default.
- Q87561915 P2860 Q43575061 @default.
- Q87561915 P2860 Q44562612 @default.
- Q87561915 P2860 Q46025071 @default.
- Q87561915 P2860 Q47582438 @default.
- Q87561915 P2860 Q47963607 @default.
- Q87561915 P2860 Q51369334 @default.
- Q87561915 P2860 Q53135049 @default.
- Q87561915 P2860 Q53390272 @default.
- Q87561915 P2860 Q56988029 @default.
- Q87561915 P2860 Q73218725 @default.
- Q87561915 P2860 Q84205421 @default.
- Q87561915 P304 "3191-3198" @default.
- Q87561915 P31 Q13442814 @default.
- Q87561915 P356 "10.1007/S00330-014-3378-4" @default.
- Q87561915 P433 "12" @default.
- Q87561915 P478 "24" @default.
- Q87561915 P577 "2014-08-12T00:00:00Z" @default.
- Q87561915 P698 "25117746" @default.
- Q87561915 P921 Q4833719 @default.